Life value

STELLAPHARM was born to care and protect patient’s health, to help enhancing their lives and living longer. Your health, for today and for future.

U.S. government to buy $1 billion more worth of Merck's COVID-19 pill

(Reuters) – The U.S. government will buy another $1 billion worth of the COVID-19 pill made by Merck & Co Inc and partner Ridgeback Biotherapeutics, the companies said on Tuesday. The government in June agreed to buy 1.7 million courses of molnupiravir for $1.2 billion and is now exercising options to buy 1.4 million more.

Japan to pay $1.2 billion for 1.6 mln courses of Merck's COVID-19 pill

Nov 10 (Reuters) – Merck & Co Inc (MRK.N) and partner Ridgeback Biotherapeutics said on Wednesday the Japanese government will pay about $1.2 billion for 1.6 million courses of their COVID-19 antiviral pill molnupiravir. Countries have rushed to sign deals to buy molnupiravir, since data last month showed that when given early in the illness

Merck expects Covid pill to reach rich and poor countries simultaneously

Washington (AFP) – US pharmaceutical giant Merck has vowed to avoid the pitfalls of the global Covid vaccine rollout by ensuring its new anti-coronavirus pill is made available in wealthy and poor countries at almost the same time. Paul Schaper, the company’s executive director of global public policy, told AFP that Merck began working on

India could approve Covid pill in matter of days

Molnupiravir can be taken as a pill instead of injection or intravenous administration. Antiviral drug Molnupiravir, used for treating mild to moderate Covid-19 infections, is set to enter the Indian markets within days, an official confirmed on Wednesday. Manufactured by US drug companies Merck, Sharp and Dohme, Molnupiravir is among the first proven drugs to

First oral antiviral for COVID-19, Lagevrio (molnupiravir), approved by MHRA

The antiviral was found to be safe and effective following a stringent review of the available evidence. The antiviral Lagevrio (molnupiravir) is safe and effective at reducing the risk of hospitalisation and death in people with mild to moderate COVID-19 who are at increased risk of developing severe disease, the Medicines and Healthcare products Regulatory

KHMER Ministry of Health approves use of Molnupiravir to treat COVID-19 in ’emergencies’

The Ministry of Health has authorized the use of COVID-19 drug Molnupiravir for emergency conditions. The Ministry said that Molnupiravir is an oral and oral anti-COVID pill that is safe and highly effective for treating COVID-19. Molnupiravir is manufactured by Mylan Laboratories Limited, based in India. The Ministry of Health states that the conditions for

Merck says research shows its COVID-19 pill works against variants

Sept 29 (Reuters) – Laboratory studies show that Merck & Co’s (MRK.N) experimental oral COVID-19 antiviral drug, molnupiravir, is likely to be effective against known variants of the coronavirus, including the dominant, highly transmissible Delta, the company said on Wednesday. Since molnupiravir does not target the spike protein of the virus – the target of

Countries in Asia are placing orders for a new drug to treat coronavirus. Poorer nations could miss out again

(CNN)During the global scramble to secure vaccines, many countries in Asia-Pacific were slow off the mark. This time, they’re not making the same mistake.Countries around the region are rushing to place orders for the latest weapon against Covid-19: an antiviral pill that isn’t even authorized for use yet. Molnupiravir — produced by US pharmaceutical company

Merck says its new Covid pill reduces the risk of hospitalization, death by half for some patients

Merck and Ridgeback Biotherapeutics said Friday they’ve developed a drug that reduces the risk of hospitalization or death by around 50% for patients with mild or moderate cases of Covid. The companies plan to seek emergency authorization for the antiviral Covid treatment after the medicine showed “compelling results” in clinical trials. The drug, molnupiravir, is

New antiviral pill halves risk of COVID-19 hospitalization, Merck says

In a late-stage clinical trial, a new antiviral pill halved the chance that patients diagnosed with COVID-19 would end up in the hospital or die from the disease, the drugmaker Merck announced Friday (Oct. 1). The drug, called molnupiravir, was developed by Merck and Ridgeback Biotherapeutics and could be the first oral medication specifically approved

Will New Covid Treatments Be as Elusive for Poor Countries as Vaccines?

By Stephanie NolenOct. 17, 2021 Merck has taken a step to make its antiviral pill available in poor nations, but many obstacles remain for broad access to coronavirus drugs. Nearly a year after the first Covid-19 vaccination campaigns began, the vast majority of the shots have gone to people in wealthy nations, with no clear

Molnupiravir – an oral antiviral treatment for COVID-19

A novel coronavirus, originally identified in Wuhan City, China, was reported to the World Health Organization on 31 December 2019, and the associated disease has subsequently become a worldwide pandemic. An effective antiviral therapeutic has since been intensively sought. Coronaviruses use an RNA-dependent RNA polymerase (RdRp) for the replication and transcription of their RNA genome.

An oral pill for COVID-19? Molnupiravir shows promise

[Updated to July 2021] The results of the trial demonstrate the safety, tolerability, and antiviral efficacy of molnupiravir to reduce replication of SARS-CoV-2 and accelerate clearance of infectious virus and support ongoing trials of molnupiravir to prevent progression of COVID-19 and eliminate onward transmission of SARS-CoV-2. After more than one year into the coronavirus disease

Ho Chi Minh City uses Molnupiravir for treating Covid-19 patients at home

According to Minister of Health Nguyen Thanh Long, the Ministry of Health and the Department of Health of Ho Chi Minh City start using the experimental antiviral drug Molnupiravir to treat Covid-19 patients with mild-symptom from August 27, 2021. He said this while inspecting the Covid-19 prevention and control task in Ho Chi Minh City’s

Stellapharm supports European partners in Covid-19 pandemic

Since the beginning of February this year, many consignments of Stella's pharmaceutical products with a total of nearly 200 million units have been urgently exported by air to markets in Germany, France, Austria, Belgium, Ireland, etc.

Company Name Change

STADA - VN JOINT VENTURE CO., LTD. officially changed its name to STELLAPHARM J.V. CO., LTD. since 16 August 2019.

We produce a wide
range of prescription
and non-prescription drugs

Xelostad 10

Xelostad 10 is used for prevention of venous thromboembolism (VTE) in adult patients, treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults

Ribastad 200

Ribastad 200 is indicated for the treatment of hepatitis C, haemorrhagic fevers.

Bicimax

Bicimax is used for supplementation of deficiencies of the vitamins B complex, vitamin C, calcium and magnesium: e.g., prolonged stress, prolonged infection and fever, intestinal diseases, gastrectomy, alcohol abuse, ...

Vitamin C STELLA 1 g

Vitamin C STELLA 1 g is used in treatment of scurvy and supplement of ascorbic acid.

Pravitce

Pravitce is as an adjuvant in colds, influenza and deficiency of Calcium and Vitamin C.

Partamol Tab.

Partamol Tab. is used for treatment of mild to moderate pain and fever, especially in patients in whom salicylates are contraindicated or not tolerated.

Partamol Extra

Partamol Extra is fixed-combination of paracetamol and ibuprofen that is indicated in management of mild to moderate pain and inflammation.

Prednisolone STELLA 5 mg

Prednisone is a synthetic, anti-inflammatory glucocorticoid.

Predstad 20

Treatment and/or suppression of inflammatory and allergic disorders.

Stadsone 4

Stadsone 4 is an anti-inflammatory or immunosuppressive treatment for some diseases including causes due to hematology, allergies, arthritis, cancer and autoimmune.

Stadsone 16

Stadsone 16 is an anti-inflammatory or immunosuppressive treatment for some diseases including causes due to hematology, allergies, arthritis, cancer and autoimmune.

Statripsine

Statripsine is used for treatment of post traumatic, post-operative oedema, burn.

Tadalafil STELLA 20 mg

Tadalafil STELLA 20 mg is used in the management of erectile dysfunction.

Odistad 120

Odistad 120 is used for conjunction with a mildly hypocaloric diet for the treatment of obese patients (BMI ≥ 30 kg/m2) or overweight patients (BMI ≥ 28 kg/m2) with associated risk factors (hypertension, diabetes mellitus, hyperlipidemia).

Mopristad 5

Mopristad 5 is indicated for the treatment of Gastrointestinal symptoms (heartburn, nausea/vomiting) associated with functional dyspepsia (chronic gastritis).

Diclofenac STELLA Gel

Diclofenac STELLA Gel is a non-steroidal anti-inflammatory (NSAID) and analgesic preparation designed for external application.

Bamstad

Bamstad is indicated for management of asthma, bronchospasm and/or reversible airways obstruction in adults.

Stadgentri

Stadgentri is a topical cream combining the anti-inflammatory, antipruritic actions of betamethasone with the antifungal activity of clotrimazole and the broad-spectrum antibiotic activity of gentamicin sulfate.

Shaping Tomorrow

We are embracing technology and partnership to leverage that strengthen to advance research, develop and produce new generic drugs.